First data on HIV-1 resistance mutations to antiretroviral drugs in Central African Republic

AIDS Research and Human Retroviruses

Volumn 26, Issue 11, 2010, Pages 1247-1248

  Moussa, Sandrine ^a   Pinson, Patricia ^b   Pelembi, Pulchérie ^a   Gody, Jean Chrysostome ^c   Mbitikon, Olivia ^c   Fikouma, Valentin ^d   Mbay, Paulette ^d   Fleury, Hervé J ^b  

^a INSTITUT PASTEUR DE BANGUI   (Central African Republic)

^b University Victor Segalen   (France)

^c Complexe Pédiatrique ^*  (Central African Republic)

^d Hopital Communautaire (CTA/CRF) de Bangui   (Central African Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CENTRAL AFRICA; CHILD; DRUG TREATMENT FAILURE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS GENOME; VIRUS ISOLATION; VIRUS MUTATION;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANTI-RETROVIRAL AGENTS; CENTRAL AFRICAN REPUBLIC; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, VIRAL; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; SEQUENCE ANALYSIS, DNA; TREATMENT FAILURE; YOUNG ADULT;

EID: 78649258659     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0091     Document Type: Article

References (8)

1. Massanga M, Ndoyo J, Hu DJ, et al.: A highly heterogeneous HIV-1 epidemic in the Central African Republic. Emerg Infect Dis 1996;2:222-224.
2. Müller-Trutwin MC, Chaix ML, Letourneur F, et al.: Increase of HIV-1 subtype A in Central African Republic. J Acquir Immune Defic Syndr 1999;21:164-171.
3. Montavon C, Vergne L, Bourgeois A, et al.: Identification of a new circulating recombinant form of HIV type 1, CRF11-cpx, involving subtypes A, G, J, and CRF01-AE, in Central Africa. AIDS Res Hum Retroviruses 2002;18:231-236. (Pubitemid 34161244)
4. Bégaud E, Feindirongai G, Versmisse P, et al.: Broad spectrum of coreceptor usage and rapid disease progression in HIV-1-infected individuals from Central African Republic. AIDS Res Hum Retroviruses. 2003;19:551-560.
5. Marechal V, Jauvin V, Selekon B, et al.: Increasing HIV type 1 polymorphic diversity but no resistance to antiretroviral drugs in untreated patients from Central African Republic: A 2005 study. AIDS Res Hum Retroviruses 2006;22:1036-1044.
6. Kantor R: Impact of HIV-1 pol diversity on drug resistance and its clinical implications. Curr Opin Infect Dis 2006;19:594-606. (Pubitemid 44665467)
7. Brenner BG: Resistance and viral subtypes: How important are the differences and why do they occur? Curr Opin HIV AIDS 2007;2:94-102.
8. Martińez-Cajas JL, Pant-Pai N, Klein MB, and Wainberg MA: Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: A systematic review of virologic and biochemical evidence. AIDS Rev 2008;10:212-223.